Skip to main content

Table 2 Results of the univariate analysis testing the panel of cytokines and CRP

From: Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

Parameters % Pts Median Survival (CI) (mos) p Value (log rank)
IL-Iβ:    
   < 27,8 pg/ml 57 11 (5.05–16.95) 0.1761
   > 27,8 pg/ml 43 24 (14.20–33.80)  
IL-6:    
   < 4 pg/ml 40 25 (11.82–38.18) 0.0295
   > 4 pg/ml 60 9 (5.44–12.56)  
IL-8:    
   < 50,7 pg/ml 62 17 (0.00–34.06) 0.0370
   > 50,7 pg/ml 38 9 (0.00–23.16)  
IL-10:    
   < 0 pg/ml 19 19 (1.82–36.18) 0.3954
   > 0 pg/ml 81 15 (7.04–22.96)  
IL-12:    
   < 5,2 pg/ml 64 15 (6.93–23.07) 0.0882
   > 5,2 pg/ml 36 25 (19.87–30.13)  
TNF-α:    
   < 0 pg/ml 19 7 (0.80–13.20) 0.1159
   > 0 pg/ml 81 20 (10.56–29.44)  
CRP:    
   < 0,8 mg/dl 46 31 (21.29–40.71) < 0.0001
   > 0,8 mg/dl 54 8 (5.68–10.32)  
  1. Abbreviations: CRP, C-reactive protein; IL, interleukin; TNF, tumor necrosis factor